Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation.
暂无分享,去创建一个
Martin Bienengraeber | Andre Terzic | Timothy M Olson | A. Terzic | A. Jahangir | A. Alekseev | L. Zingman | M. Bienengraeber | T. Olson | J. D. Ballew | Jeffrey D Ballew | Leonid V Zingman | Alexey E Alekseev | Arshad Jahangir | Sungjo Park | Xiaoke K Liu | Srinivasan Sattiraju | Jeffrey D. Ballew | Sungjo Park | Xiaoke Liu | S. Sattiraju
[1] D. Roden,et al. Human cardiac potassium channel DNA polymorphism modulates access to drug-binding site and causes drug resistance. , 2005, The Journal of clinical investigation.
[2] B. Fermini,et al. Adrenergic modulation of ultrarapid delayed rectifier K+ current in human atrial myocytes. , 1996, Circulation research.
[3] G. Koren,et al. Assembly of mammalian voltage-gated potassium channels: Evidence for an important role of the first transmembrane segment , 1994, Neuron.
[4] E. Braunwald. Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.
[5] S. Bendahhou,et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. , 2004, American journal of human genetics.
[6] Wei Huang,et al. KCNQ1 Gain-of-Function Mutation in Familial Atrial Fibrillation , 2003, Science.
[7] Frances M. Ashcroft,et al. From molecule to malady , 2006, Nature.
[8] B. Kerem,et al. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. , 2003, The New England journal of medicine.
[9] B. Gersh,et al. Epidemiology and natural history of atrial fibrillation: clinical implications. , 2001, Journal of the American College of Cardiology.
[10] J. Seidman,et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. , 1999, The New England journal of medicine.
[11] M. Cadene,et al. X-ray structure of a voltage-dependent K+ channel , 2003, Nature.
[12] D. Roden,et al. Polymorphism Screening in the Cardiac K+ Channel Gene KCNA5 , 2005, Clinical pharmacology and therapeutics.
[13] A. E. Alekseev,et al. Bacterial enterotoxins are associated with resistance to colon cancer , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. Levy,et al. Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study , 2004, Circulation.
[15] S Nattel,et al. Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents. , 1993, Circulation research.
[16] Douglas L Packer,et al. Familial atrial fibrillation is a genetically heterogeneous disorder. , 2003, Journal of the American College of Cardiology.
[17] Yusong He,et al. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. , 2005, Biochemical and biophysical research communications.
[18] J. Brugada,et al. Identification of a genetic locus for familial atrial fibrillation. , 1997, The New England journal of medicine.
[19] D. Bedwell,et al. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations , 1996, Nature Medicine.
[20] J. Nerbonne,et al. Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. , 1997, Circulation research.
[21] A. Terzic,et al. Kir6.2 is required for adaptation to stress , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[22] Ralph B. D'Agostino,et al. Parental Atrial Fibrillation as a Risk Factor for Atrial Fibrillation in Offspring , 2004 .
[23] D. Roden,et al. Molecular cloning and characterization of two voltage‐gated K+ channel cDNAs from human ventricle , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] S. Nattel. New ideas about atrial fibrillation 50 years on , 2002, Nature.
[25] P. Wolf,et al. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. , 1985, JAMA.
[26] M. Sanguinetti,et al. Molecular and Cellular Mechanisms of Cardiac Arrhythmias , 2001, Cell.
[27] Jeffrey L. Anderson,et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. , 2005, JAMA.
[28] Yuan-Ping Pang,et al. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating , 2004, Nature Genetics.
[29] B. Gersh,et al. The natural history of lone atrial fibrillation. A population-based study over three decades. , 1987, The New England journal of medicine.
[30] 李永军,et al. Atrial Fibrillation , 1999 .
[31] S. Nattel,et al. Atrial fibrillation-associated minK38G/S polymorphism modulates delayed rectifier current and membrane localization. , 2005, Cardiovascular research.
[32] K. Stefánsson,et al. Familial aggregation of atrial fibrillation in Iceland. , 2006, European heart journal.
[33] S. Nattel,et al. Antisense oligodeoxynucleotides directed against Kv1.5 mRNA specifically inhibit ultrarapid delayed rectifier K+ current in cultured adult human atrial myocytes. , 1997, Circulation research.
[34] V. Fuster. Atrial fibrillation: an epidemiologic, scientific and clinical challenge , 2005, Nature Clinical Practice Cardiovascular Medicine.
[35] D. Zipes,et al. Cesium‐Induced Atrial Tachycardia Degenerating into Atrial Fibrillation in Dogs: Atrial Torsades de Pointes? , 1998, Journal of cardiovascular electrophysiology.